Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply. Kopetz S, Grothey A, Tabernero J. N Engl J Med 2020;382:877-878.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kopetz S, Grothey A, Tabernero J. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply. N Engl J Med 2020;382:877-878.
PMID: 32101678